VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

NCT02146222 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: VEGFR/PDGFR dual kinase inhibitor X-82
DRUG: docetaxel
OTHER: fluorine F 18 fluorothymidine
PROCEDURE: positron emission tomography/computed tomography
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]